Earnings calendar/PEPL
PepperLime Health Acquisition Corporation (PEPL)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter PepperLime Health Acquisition Corporation has filed, from EvidInvest's standardized statements.
Period end
Sep 30, 2023
Q3 FY2023
Filed
Nov 13, 2023
Filing date on record
EPS (diluted)
$-0.04
No estimate on record
Revenue
$0
As filed
Net income
$-207,829
As filed
EPS YoY
-114.3%
vs quarter ended 2022-09-30
Revenue YoY
—
vs quarter ended 2022-09-30
Next report
Nov 9, 2026
Estimated from filing cadence
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$0.20
2022-12-31 through 2023-09-30
TTM revenue
$0
2022-12-31 through 2023-09-30
Filed quarters
9
On record here
Next revenue estimate
—
No estimate on record
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY |
|---|---|---|---|---|---|
| 2023-09-30Q3 FY2023 | 2023-11-13 | $-0.04 | $0 | -114.3% | — |
| 2023-06-30Q2 FY2023 | 2023-08-07 | $0.02 | $0 | -50.0% | — |
| 2023-03-31Q1 FY2023 | 2023-05-15 | $0.11 | $0 | +650.0% | — |
| 2022-12-31Q4 FY2022 | 2023-03-28 | $0.11 | $0 | — | — |
| 2022-09-30Q3 FY2022 | 2022-11-04 | $0.28 | $0 | — | — |
| 2022-06-30Q2 FY2022 | 2022-08-05 | $0.04 | $0 | — | — |
| 2022-03-31Q1 FY2022 | 2022-05-13 | $-0.02 | $0 | — | — |
| 2021-12-31Q4 FY2021 | 2022-03-17 | $0.00 | $0 | — | — |
| 2021-09-30Q3 FY2021 | 2021-11-24 | $0.00 | $0 | — | — |
More on PepperLime Health Acquisition Corporation
Compare with peers
- USSX · Corgi U.S. Small-Cap 2x Daily ETF
- PTACW · Patriot Acquisition Corp.
- USMX · Corgi U.S. Mid-Cap 2x Daily ETF
- VSMPX · Vanguard Morningstar Total Stock Market Index Fund Institutional Plus Shares
- VTSAX · Vanguard Total Stock Market Index Fund Admiral Shares
- VITSX · Vanguard Total Stock Market Index Fund Institutional Shares